A detailed history of N Verses Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 6,500 shares of VCYT stock, worth $242,710. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,500
Previous 3,900 66.67%
Holding current value
$242,710
Previous $84.5 Million 161.81%
% of portfolio
0.1%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$21.0 - $35.25 $54,600 - $91,650
2,600 Added 66.67%
6,500 $221 Million
Q2 2024

Jul 31, 2024

BUY
$18.86 - $23.55 $73,554 - $91,845
3,900 New
3,900 $84.5 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.67B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.